Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research

Over the past two decades, our understanding of Parkinson's disease (PD) has been gleaned from the discoveries made in familial and/or sporadic forms of PD in the Caucasian population. The transferability and the clinical utility of genetic discoveries to other ethnically diverse populations are unknown. The Indian population has been under-represented in PD research. The Genetic Architecture of PD in India (GAP-India) project aims to develop one of the largest clinical/genomic bio-bank for PD in India. Specifically, GAP-India project aims to: (1) develop a pan-Indian deeply phenotyped clinical repository of Indian PD patients; (2) perform whole-genome sequencing in 500 PD samples to catalog Indian genetic variability and to develop an Indian PD map for the scientific community; (3) perform a genome-wide association study to identify novel loci for PD and (4) develop a user-friendly web-portal to disseminate results for the scientific community. Our “hub-spoke” model follows an integrative approach to develop a pan-Indian outreach to develop a comprehensive cohort for PD research in India. The alignment of standard operating procedures for recruiting patients and collecting biospecimens with international standards ensures harmonization of data/bio-specimen collection at the beginning and also ensures stringent quality control parameters for sample processing. Data sharing and protection policies follow the guidelines established by local and national authorities.We are currently in the recruitment phase targeting recruitment of 10,200 PD patients and 10,200 healthy volunteers by the end of 2020. GAP-India project after its completion will fill a critical gap that exists in PD research and will contribute a comprehensive genetic catalog of the Indian PD population to identify novel targets for PD.

[1]  Sonja W. Scholz,et al.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.

[2]  S. Ossowski,et al.  ClinCNV: novel method for allele-specific somatic copy-number alterations detection , 2019, bioRxiv.

[3]  Dirk von Suchodoletz,et al.  Proceedings of the 5th bwHPC Symposium , 2019 .

[4]  Jens Krüger,et al.  de.NBI Cloud Storage Tübingen. A federated and georedundant solution for large scientific data , 2019 .

[5]  Lisle E Mose,et al.  Improved indel detection in DNA and RNA via realignment with ABRA2 , 2019, Bioinform..

[6]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[7]  A. Kishore,et al.  Understanding the role of genetic variability in LRRK2 in Indian population , 2018, Movement disorders : official journal of the Movement Disorder Society.

[8]  Yoshihiro Kokubo,et al.  Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[9]  S. Swaminathan,et al.  National ethical guidelines for biomedical & health research involving human participants, 2017: A commentary , 2018, The Indian journal of medical research.

[10]  Andries T Marees,et al.  A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis , 2018, International journal of methods in psychiatric research.

[11]  A. Xie,et al.  Association between rs823128 polymorphism and the risk of Parkinson’s disease: A meta-analysis , 2018, Neuroscience Letters.

[12]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[13]  M. Nalls,et al.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.

[14]  F. Arnaud,et al.  From core referencing to data re-use: two French national initiatives to reinforce paleodata stewardship (National Cyber Core Repository and LTER France Retro-Observatory) , 2017 .

[15]  A. Choudhury,et al.  Population Stratification and Underrepresentation of Indian Subcontinent Genetic Diversity in the 1000 Genomes Project Dataset , 2016, Genome biology and evolution.

[16]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[17]  Peter Bauer,et al.  SeqPurge: highly-sensitive adapter trimming for paired-end NGS data , 2016, BMC Bioinformatics.

[18]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[19]  David Kulp,et al.  A guide to genome‐wide association analysis and post‐analytic interrogation , 2015, Statistics in medicine.

[20]  Jack Euesden,et al.  PRSice: Polygenic Risk Score software , 2014, Bioinform..

[21]  J. Long,et al.  Illumina human exome genotyping array clustering and quality control , 2014, Nature Protocols.

[22]  Ira M. Hall,et al.  SAMBLASTER: fast duplicate marking and structural variant read extraction , 2014, Bioinform..

[23]  Bonnie Berger,et al.  Genetic evidence for recent population mixture in India. , 2013, American journal of human genetics.

[24]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[25]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[26]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[27]  A. Ramesh,et al.  The SNCA (A53T, A30P, E46K) and LRRK2 (G2019S) mutations are rare cause of Parkinson's disease in South Indian patients. , 2012, Parkinsonism & related disorders.

[28]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[29]  A. Kishore,et al.  LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India. , 2011, Neurology India.

[30]  V. Rao,et al.  Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients. , 2010, Genetic testing and molecular biomarkers.

[31]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[32]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[33]  M. King,et al.  Genetic Heterogeneity in Human Disease , 2010, Cell.

[34]  V. Preedy,et al.  Unified Parkinson's Disease Rating Scale , 2010 .

[35]  Alkes L. Price,et al.  Reconstructing Indian Population History , 2009, Nature.

[36]  John P A Ioannidis,et al.  Meta-analysis in genome-wide association studies. , 2009, Pharmacogenomics.

[37]  F. Schmidt Meta-Analysis , 2008 .

[38]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[39]  U. Muthane,et al.  Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients , 2006, Neuroscience Letters.

[40]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[41]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[42]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[43]  R. F. Allen A Commentary , 1966 .